Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

2.140 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.140
Bid (Size) 1.100 (1)
Ask (Size) 3.420 (2)
Prev. Close 2.140
Today's Range 2.140 - 2.140
52wk Range 0.9200 - 7.798
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Insiders Buying Taysha Gene Therapies And 3 Other Stocks Under $2
The Dow Jones closed higher by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Recap: Omeros Q3 Earnings
Via Benzinga

Performance

YTD
-13.71%
-13.71%
1 Month
+87.72%
+87.72%
3 Month
-41.37%
-41.37%
6 Month
-65.48%
-65.48%
1 Year
+8.08%
+8.08%

More News

Read More
Omeros Corporation Reports Third Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
Earnings Preview: Omeros
Via Benzinga
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023
From Omeros Corporation
Via Business Wire
Why Omeros Corporation (OMER) Shares Are Nosediving
Via Benzinga
Earnings Preview: Omeros
Via Benzinga
Why Shares of Omeros Dropped on Monday
Via The Motley Fool
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
From Omeros Corporation
Via Business Wire
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
From Omeros Corporation
Via Business Wire
Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer
From Omeros Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Crude Oil Moves Lower; Consolidated Communications Shares Jump
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Gains 1%; Charles Schwab Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
From Omeros Corporation
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Omeros Corporation Reports Second Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
From Omeros Corporation
Via Business Wire
Omeros Announces Webcast Details for Annual Meeting of Shareholders
From Omeros Corporation
Via Business Wire
Nasdaq, Methanex And Other Big Stocks Moving Lower On Monday
Via Benzinga
Omeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association Congress
From Omeros Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.